Lucentis
Patient Information
PATIENT INFORMATION
PATIENT COUNSELING INFORMATION
In the days following LUCENTIS administration, patients are at risk of developing endophthalmitis. If the eye becomes red, sensitive to light, painful, or develops a change in vision, the patient should seek immediate care from an ophthalmologist [see WARNINGS AND PRECAUTIONS].
Brand Name: Lucentis
Generic Name: Ranibizumab Injection
Generic Name: Ranibizumab Injection
« Previous: Lucentis - Clinical Pharmacology
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Bookmark this page:
WebMD Daily
Get breaking medical news.
WebMD Resources
Health Extras
Glaucoma Laser Treatment
Glaucoma is a sight-stealing condition caused by pressure in the eye. Now patients are finding results through glaucoma laser treatment. See more WebMD Videos »
Lucentis
Health Resources
Updated & New
RxList does not provide medical advice, diagnosis or treatment.